Vitamin and minerals supplements: Required for good health?;Vitamin- og mineraltilskudd - Nødvendig for god helse?

Tidsskrift for den Norske Laegeforening

Volumn 124, Issue 12, 2004, Pages 1646-1649

  Meltzer, Helle Margrete ^a   Haugen, Margaretha ^a   Alexander, Jan ^a   Pedersen, Jan I ^b  

^a Avd for Naeringsmiddeltoksikologi   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; FOLIC ACID; IRON; MINERAL; MULTIVITAMIN; VITAMIN; VITAMIN D;

ANIMAL EXPERIMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; EUROPEAN UNION; EVIDENCE BASED MEDICINE; HEALTH; HIGH RISK POPULATION; HUMAN; IRON THERAPY; MINERAL BALANCE; NONHUMAN; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAFETY; SCANDINAVIA; THERAPY; UNITED STATES; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASE; CONSENSUS; DIET SUPPLEMENTATION; DOSE RESPONSE; FEMALE; HEALTH STATUS; MALE; NUTRITIONAL REQUIREMENT; PRACTICE GUIDELINE; RESEARCH;

CARDIOVASCULAR DISEASES; CONSENSUS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH STATUS; HUMANS; MALE; MINERALS; NUTRITIONAL REQUIREMENTS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RESEARCH; VITAMIN E; VITAMINS;

EID: 3042639778     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Stampfer MJ, Hennekens CH, Manson JE et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-9.
2. Rimm EB, Stampfer MJ, Ascherio A et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6.
3. Virtamo J, Rapola JM, Ripatti S et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998; 158: 668-75.
4. Stephens NG, Parsons A, Schofield PM et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-6.
5. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354: 447-55.
6. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154-60.
7. Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-8.
8. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89-95.
9. Leppala JM, Virtamo J, Fogelholm R et al. Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Arch Neurol 2000; 57: 1503-9.
10. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23-33.
11. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 1029-35.
12. Rapola JM, Virtamo J, Ripatti S et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction. Lancet 1997; 349: 1715-20.
13. Meltzer HM, Meyer HE, Klepp K-I. Fra hypotese til kostråd - veier, snarveier og blindveier. Tidsskr Nor Lægeforen 2004; 124: 1248-50.
14. Sandström B, Aro A, Becker W et al. Nordiska nä ringsrekommendationer 1996. København: Nordisk ministerråd, 1996.
15. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes: a risk assessment model for establishing upper intake levels for nutrients. Washington D.C.: National Academy Press, 1998.
16. WHO. Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits. Environmental Health Criteria 1994; volume 170.
17. Reports of the Scientific Committee for Food. Nutrient and energy intakes for the European Community. Luxembourg: Commission of the European Communities, 1993.
18. Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001; 101: 294-301.
19. Meltzer HM, Aro A, Andersen NL et al. Risk analysis applied to food fortification. Public Health Nutr 2003; 6: 281-90.
20. Bendich A, Machlin LJ. The safety of oral intake of vitamin E: data from clinical studies from 1986 to 1991. I: Packer I, Fuchs J, red. Vitamin E in health and disease. New York: Marcel Decker, 1993: 411-6.
21. Vatassery GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr 1999; 70: 793-801.
22. Johansson L, Solvoll K. Norkost 1997. Landsomfattende kostholdsundersøkelse blant menn og kvinner i alderen 16-79 år. Rapport nr. 2/1999. Oslo: Statens råd for ernæring og fysisk aktivitet, 1999.
23. Similä M, Fagt S, Vaask S et al. The NORBA-GREEN 2002 study. TemaNord 2003: 556. København: Nordisk ministerråd, 2003.
24. Norges offentlige utredninger. Alternativ medisin. NOU 1998: 21. Oslo, Statens forvaltningstjeneste, Seksjon Statens trykning, 1998.
25. Hemila H. Vitamin C intake and susceptibility to the common cold. Br J Nutr 1997; 77: 59-72.
26. Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002; 75: 616-58.